Consequences of oral antithrombotic use in patients with chronic kidney disease

We assessed the risks of bleeding, acute kidney injury (AKI), and kidney failure associated with the prescription of antithrombotic agents (oral anticoagulants and/or antiplatelet agents) in patients with moderate‐to‐advanced chronic kidney disease (CKD). CKD‐REIN is a prospective cohort of 3022 nep...

Descripción completa

Detalles Bibliográficos
Autores principales: Laville, Solène M., Lambert, Oriane, Hamroun, Aghiles, Metzger, Marie, Jacquelinet, Christian, Laville, Maurice, Frimat, Luc, Fouque, Denis, Combe, Christian, Ayav, Carole, Pecoits‐Filho, Roberto, Stengel, Bénédicte, Massy, Ziad A., Liabeuf, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604253/
https://www.ncbi.nlm.nih.gov/pubmed/34080321
http://dx.doi.org/10.1111/cts.13084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604253/
https://www.ncbi.nlm.nih.gov/pubmed/34080321
http://dx.doi.org/10.1111/cts.13084

Ejemplares similares